「pr」の検索結果
229件：151～155件目を表示
-
ical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (He...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
ical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (He...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
vel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a compound (development code: SJP-0...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeApplication under review（Japan）...
http://www.senju.co.jp/english/rd/pipeline.html -
产品开发方针 | 研究与开发 | 千寿制药株式会社
。 #1: 井上 佐智子, 川岛 素子, 坪田 一男：什么是干眼症？从原因到最新的治疗，Farumashia，2014 50(3): 201-6 #2: Papas EB. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-66. #3: Uni...
http://www.senju.co.jp/chinese/rd/policy/